BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 18071986)

  • 1. Atypical meningiomas: WHO moved the goalposts?
    Smith SJ; Boddu S; Macarthur DC
    Br J Neurosurg; 2007 Dec; 21(6):588-92. PubMed ID: 18071986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The accuracy of meningioma grading: a 10-year retrospective audit.
    Willis J; Smith C; Ironside JW; Erridge S; Whittle IR; Everington D
    Neuropathol Appl Neurobiol; 2005 Apr; 31(2):141-9. PubMed ID: 15771707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved correlation of the neuropathologic classification according to adapted world health organization classification and outcome after radiotherapy in patients with atypical and anaplastic meningiomas.
    Combs SE; Schulz-Ertner D; Debus J; von Deimling A; Hartmann C
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1415-21. PubMed ID: 20932661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Meningiomas: new prognostic factors].
    Sanz Esponera J
    An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Atypical and malignant intracranial meningiomas].
    Gelabert-González M; Fernández-Villa JM; Iglesias-Pais M
    Rev Neurol; 2004 Feb 16-29; 38(4):304-10. PubMed ID: 14997451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Atypical, aplastic, and unusual meningiomas. Morphology and incidence in 300 consecutive cases].
    Buccoliero AM; Caldarella A; Taddei A; Di Lorenzo N; Gallina P; Mennonna P; Ammannati F; Taddei GL
    Pathologica; 2003 Apr; 95(2):83-7. PubMed ID: 12768876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between malignant subtypes of meningioma and clinical outcome.
    Ko KW; Nam DH; Kong DS; Lee JI; Park K; Kim JH
    J Clin Neurosci; 2007 Aug; 14(8):747-53. PubMed ID: 17499508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interinstitutional variance of postoperative radiotherapy and follow up for meningiomas in Germany: impact of changes of the WHO classification.
    Simon M; Boström J; Koch P; Schramm J
    J Neurol Neurosurg Psychiatry; 2006 Jun; 77(6):767-73. PubMed ID: 16306156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Childhood and adolescent meningiomas: a report of 38 cases and review of literature.
    Menon G; Nair S; Sudhir J; Rao BR; Mathew A; Bahuleyan B
    Acta Neurochir (Wien); 2009 Mar; 151(3):239-44; discussion 244. PubMed ID: 19238320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin predicts the behaviour of atypical meningioma.
    Lin CK; Tsai WC; Lin YC; Hueng DY
    Histopathology; 2012 Jan; 60(2):320-5. PubMed ID: 22211290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of intermediate type (WHO "atypical") meningiomas.
    Niedermayer I; Kolles H; Zang KD; Feiden W
    Clin Neuropathol; 1996; 15(6):330-6. PubMed ID: 8937779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of DNA content and nucleomorphometric features with World Health Organization grading of meningiomas.
    Grunewald JP; Röhl FW; Kirches E; Dietzmann K
    Mod Pathol; 1998 Feb; 11(2):216-23. PubMed ID: 9504694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term experience with World Health Organization grade III (malignant) meningiomas at a single institution.
    Rosenberg LA; Prayson RA; Lee J; Reddy C; Chao ST; Barnett GH; Vogelbaum MA; Suh JH
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):427-32. PubMed ID: 19427553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meningioma.
    Marosi C; Hassler M; Roessler K; Reni M; Sant M; Mazza E; Vecht C
    Crit Rev Oncol Hematol; 2008 Aug; 67(2):153-71. PubMed ID: 18342535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of stereotactic radiosurgery in the management of meningiomas.
    Malik I; Rowe JG; Walton L; Radatz MW; Kemeny AA
    Br J Neurosurg; 2005 Feb; 19(1):13-20. PubMed ID: 16147577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The molecular genetics of meningiomas and genotypic/phenotypic correlations].
    Dezamis E; Sanson M
    Rev Neurol (Paris); 2003 Sep; 159(8-9):727-38. PubMed ID: 13679715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic validity of the Ki-67 labeling index using the MIB-1 monoclonal antibody in the grading of meningiomas.
    Devaprasath A; Chacko G
    Neurol India; 2003 Sep; 51(3):336-40. PubMed ID: 14652433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crush preparations of meningiomas: can grading be accomplished?
    Ali S; Nassar A; Siddiqui MT
    Diagn Cytopathol; 2008 Nov; 36(11):827-31. PubMed ID: 18831022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hitting a moving target: evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteria.
    Pearson BE; Markert JM; Fisher WS; Guthrie BL; Fiveash JB; Palmer CA; Riley K
    Neurosurg Focus; 2008; 24(5):E3. PubMed ID: 18447742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiosurgery as definitive management of intracranial meningiomas.
    Kondziolka D; Mathieu D; Lunsford LD; Martin JJ; Madhok R; Niranjan A; Flickinger JC
    Neurosurgery; 2008 Jan; 62(1):53-8; discussion 58-60. PubMed ID: 18300891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.